@yuvalpatelMD@ebtapper@rrosenblattmd @AutoImmuneLiver @HowardTLeeMD I’d usually try an initial wean (steroids first then MMF) as soon as enzymes are normal. Although few factors eg plans to rechallenge, initially severity etc will influence this
Behind the fanfare of GP telehealth numbers becoming permanent, the Federal government has introduced a whole slew of stealth cuts.
This will effective cut Medicare rebates to patients in regional and rural areas by 33% or a third.
A thread 🧵…
@melbourneliver https://t.co/AxVQ46QhU2
I don’t see any drawback to using POC ultrasound if accessible? This article has a reasonable summary of the evidence
"We need a more sophisticated understanding of the replication crisis, not as a moment of realization after which we were able to move forward with higher standards, but as an ongoing rot in the scientific process that a decade of work hasn’t quite fixed." https://t.co/D9vrEswtXZ
@GregDore2 @aelsharkawy75@stephentbarclay@ProfJohnDillon@JVLazarus It shouldn’t be mutually exclusive - how about stage those who are engaged/motivated and just go ahead and treat those who aren’t? Those who don’t attend staging workup will be unlikely to adhere to future hcc surveillance anyway.
While spontaneous yawning is common across all vertebrate classes, *contagious* yawning is less common and has been observed only in a few species of *social* animals.
But, sweetly, elephants yawn when we do. 1/
@AutoImmuneLiver @EASLedu True - I suspect all conferences moving to a hybrid model allowing both physical and digital attendances will be the way forward.
American research infrastructure is killing us: The misbegotten battle between the ivory tower academics and the rogue cowboys
(blog: https://t.co/cUIUDUeXe9)
@AndrewBuckle15 Other issues we have found:
1. People with poor hearing - particularly elderly that sometimes rely on lip reading
2. Phone interpreters on conference call can be very difficult!
3. Need to confirm address hasn’t changed prior to sending out test requests.
@kymwatt@MayoClinicGIHep on risk stratification and comorbidities in #NAFLD. Risks for bad outcomes are age, fibrosis, DM, BMI, alcohol and sarcopenia. Telmesartan might be BP drug of choice due to decrease in free fatty acids @AASLDtweets#LiverMtg19
After yesterday’s primer on fibrosis in #NASH, today we should consider the likely benefits of treatment
A NASH treatment Tweetorial, just for the @AASLD#LiverMtg19
1/n
Not all liver enzymes are from the liver!
Check out this paper that followed ALT, AST, & CK in 15 fit men after 1hr of 🏋️♂️
⬇️🏋️♂️experience,⬆️💪injury
⬆️ALT half-life > AST
Inspired to post on one of my fave papers by @drkeithsiau@stevenbollipo thread
https://t.co/0S7U9X4OUn